Diagnostic Pathway with Multiparametric Magnetic Resonance Imaging Versus Standard Pathway: Results from a Randomized Prospective Study in Biopsy-naïve Patients with Suspected Prostate CancerF. Porpiglia, Stefano De Luca, Matteo Manfredi et al.|European Urology|2016Cited by 201
The Roles of Multiparametric Magnetic Resonance Imaging, PCA3 and Prostate Health Index—Which is the Best Predictor of Prostate Cancer after a Negative Biopsy?F. Porpiglia, Daniele Regge, Cristian Fiori et al.|The Journal of Urology|2014Cited by 71
Multiparametric Magnetic Resonance/Ultrasound Fusion Prostate Biopsy: Number and Spatial Distribution of Cores for Better Index Tumor Detection and CharacterizationF. Porpiglia, Cristian Fiori, Stefano De Luca et al.|The Journal of Urology|2017Cited by 60
Multiparametric-Magnetic Resonance/Ultrasound Fusion Targeted Prostate Biopsy Improves Agreement Between Biopsy and Radical Prostatectomy Gleason ScoreF. Porpiglia, Andrea Veltri, Stefano De Luca et al.|Anticancer Research|2016Cited by 49
High prostate cancer gene 3 ( <scp>PCA</scp> 3) scores are associated with elevated Prostate Imaging Reporting and Data System ( <scp>PI</scp> ‐ <scp>RADS</scp> ) grade and biopsy Gleason score, at magnetic resonance imaging/ultrasonography fusion software‐based targeted prostate biopsy after a previous negative standard biopsyStefano De Luca, F. Porpiglia, Roberto Passera et al.|British Journal of Urology|2016Cited by 25